Similar articles

• Risks of testosterone replacement.

  Shames DA. Shames DA. N Engl J Med. 2004 May 6;350(19):2004-6; author reply 2004-6. doi: 10.1056/NEJM200405063501919. N Engl J Med. 2004. PMID: 15128905 No abstract available.
• Testosterone replacement therapy in hypogonadal men and prostate cancer risk.

  Kirby R, Gould D. Kirby R, et al. BJU Int. 2005 Sep;96(4):471-2. doi: 10.1111/j.1464-410X.2005.05665.x. BJU Int. 2005. PMID: 16104891 No abstract available.
• Risks of testosterone-replacement therapy and recommendations for monitoring.

  Rhoden EL, Morgentaler A. Rhoden EL, et al. N Engl J Med. 2004 Jan 29;350(5):482-92. doi: 10.1056/NEJMra022251. N Engl J Med. 2004. PMID: 14749457 Review. No abstract available.
• Testosterone replacement therapy and prostate cancer: a word of caution.

  Brand TC, Canby-Hagino E, Thompson IM. Brand TC, et al. Curr Urol Rep. 2007 May;8(3):185-9. doi: 10.1007/s11934-007-0004-x. Curr Urol Rep. 2007. PMID: 17459266 Review.
• Testosterone replacement therapy and the risk of prostate cancer. Is there a link?

  Barqawi A, Crawford ED. Barqawi A, et al. Int J Impot Res. 2006 Jul-Aug;18(4):323-8. doi: 10.1038/sj.ijir.3901418. Epub 2005 Nov 10. Int J Impot Res. 2006. PMID: 16281043 Review.